Literature DB >> 8351365

Catheter for percutaneous thrombectomy: first clinical experience.

J A Reekers1, J G Kromhout, K van der Waal.   

Abstract

The authors evaluated a double-lumen thrombectomy catheter that functions by way of the Venturi effect in seven consecutive patients with thrombus in the superficial femoral artery. The estimated age of the thrombotic material was between 3 days and 9 weeks. Thrombectomy was successful in all patients, and mean time required was less than 20 minutes. In five patients, diagnosis, thrombectomy, and therapeutic intervention were successfully performed in one session.

Entities:  

Mesh:

Year:  1993        PMID: 8351365     DOI: 10.1148/radiology.188.3.8351365

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Percutaneous hydrodynamic thrombectomy for congenital deep vein thrombosis in a neonate.

Authors:  T Kobayashi; T Kobayashi; H Mayuzumi; A Morikawa
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

2.  Iliocaval stenosis and iliac venous thrombosis in retroperitoneal fibrosis: percutaneous treatment by use of hydrodynamic thrombectomy and stenting.

Authors:  D Vorwerk; R W Guenther; G Wendt; J Neuerburg; K Schürmann
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Jan-Feb       Impact factor: 2.740

3.  Rheolytic thrombectomy of an acutely thrombosed transjugular intrahepatic portosystemic stent shunt.

Authors:  S Müller-Hülsbeck; J Link; M Höpfner; C Löser; M Heller
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Jul-Aug       Impact factor: 2.740

4.  Recanalization of aged venous thrombotic occlusions with the aid of a rheolytic system: an experimental study.

Authors:  C Vicol; H Dalichau
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Jul-Aug       Impact factor: 2.740

5.  Twelve years experience of vena cava filtration.

Authors:  N R Lagattolla; K G Burnand; A Irvine; D Ferrar
Journal:  Ann R Coll Surg Engl       Date:  1996-07       Impact factor: 1.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.